Cronos Group Inc (CRON)
2.06
-0.01
(-0.48%)
USD |
NASDAQ |
Nov 15, 11:53
Cronos Group Enterprise Value: -60.39M for Nov. 14, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 14, 2024 | -60.39M |
| November 13, 2024 | -22.16M |
| November 12, 2024 | 12.24M |
| November 11, 2024 | -98.62M |
| November 08, 2024 | -87.15M |
| November 07, 2024 | -64.21M |
| November 06, 2024 | -68.04M |
| November 05, 2024 | -3.048M |
| November 04, 2024 | -10.69M |
| November 01, 2024 | -25.98M |
| October 31, 2024 | -52.74M |
| October 30, 2024 | -45.10M |
| October 29, 2024 | -14.52M |
| October 28, 2024 | 0.775M |
| October 25, 2024 | -3.048M |
| October 24, 2024 | -14.52M |
| October 23, 2024 | 0.775M |
| October 22, 2024 | 23.71M |
| October 21, 2024 | -37.45M |
| October 18, 2024 | -18.34M |
| October 17, 2024 | -29.81M |
| October 16, 2024 | -25.98M |
| October 15, 2024 | -25.98M |
| October 14, 2024 | -10.69M |
| October 11, 2024 | -6.871M |
| Date | Value |
|---|---|
| October 10, 2024 | -45.10M |
| October 09, 2024 | -41.28M |
| October 08, 2024 | -22.16M |
| October 07, 2024 | -10.69M |
| October 04, 2024 | 4.598M |
| October 03, 2024 | 4.598M |
| October 02, 2024 | -25.98M |
| October 01, 2024 | -37.45M |
| September 30, 2024 | -14.52M |
| September 27, 2024 | -22.16M |
| September 26, 2024 | -14.52M |
| September 25, 2024 | -56.57M |
| September 24, 2024 | -29.81M |
| September 23, 2024 | -29.81M |
| September 20, 2024 | -29.81M |
| September 19, 2024 | 0.775M |
| September 18, 2024 | 16.07M |
| September 17, 2024 | 12.24M |
| September 16, 2024 | 4.598M |
| September 13, 2024 | -18.34M |
| September 12, 2024 | -25.98M |
| September 11, 2024 | -18.34M |
| September 10, 2024 | -10.69M |
| September 09, 2024 | -6.871M |
| September 06, 2024 | -33.63M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-203.72M
Minimum
Aug 15 2023
4.309B
Maximum
Feb 10 2021
558.13M
Average
262.23M
Median
May 18 2022
Enterprise Value Benchmarks
| Tilray Brands Inc | 1.294B |
| Aurinia Pharmaceuticals Inc | 843.94M |
| Edesa Biotech Inc | 5.103M |
| Lexaria Bioscience Corp | 24.64M |
| Xenon Pharmaceuticals Inc | 2.442B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.757M |
| Revenue (Quarterly) | 27.76M |
| Total Expenses (Quarterly) | 42.78M |
| EPS Diluted (Quarterly) | -0.02 |
| Gross Profit Margin (Quarterly) | 22.68% |
| Profit Margin (Quarterly) | -31.54% |
| Earnings Yield | -7.01% |
| Normalized Earnings Yield | -0.2789 |